- Home
- RLTY vs TSVT Comparison
RLTY vs TSVT Comparison
Compare RLTY & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLTY
- TSVT
- Stock Information
- Founded
- RLTY 2022
- TSVT 2021
- Country
- RLTY United States
- TSVT United States
- Employees
- RLTY N/A
- TSVT N/A
- Industry
- RLTY Investment Managers
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- RLTY Finance
- TSVT Health Care
- Exchange
- RLTY Nasdaq
- TSVT Nasdaq
- Market Cap
- RLTY 256.9M
- TSVT 160.4M
- IPO Year
- RLTY N/A
- TSVT N/A
- Fundamental
- Price
- RLTY $14.82
- TSVT $3.07
- Analyst Decision
- RLTY
- TSVT Buy
- Analyst Count
- RLTY 0
- TSVT 6
- Target Price
- RLTY N/A
- TSVT $10.40
- AVG Volume (30 Days)
- RLTY 86.7K
- TSVT 297.4K
- Earning Date
- RLTY 01-01-0001
- TSVT 11-12-2024
- Dividend Yield
- RLTY 9.35%
- TSVT N/A
- EPS Growth
- RLTY N/A
- TSVT N/A
- EPS
- RLTY N/A
- TSVT N/A
- Revenue
- RLTY N/A
- TSVT $45,620,000.00
- Revenue This Year
- RLTY N/A
- TSVT N/A
- Revenue Next Year
- RLTY N/A
- TSVT $36.09
- P/E Ratio
- RLTY N/A
- TSVT N/A
- Revenue Growth
- RLTY N/A
- TSVT N/A
- 52 Week Low
- RLTY $11.38
- TSVT $2.78
- 52 Week High
- RLTY $14.60
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- RLTY 22.43
- TSVT 32.27
- Support Level
- RLTY $14.56
- TSVT $2.78
- Resistance Level
- RLTY $16.00
- TSVT $4.07
- Average True Range (ATR)
- RLTY 0.26
- TSVT 0.24
- MACD
- RLTY -0.14
- TSVT -0.05
- Stochastic Oscillator
- RLTY 2.44
- TSVT 12.02
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.